Skip to Content

APO LMV 300 (Lamivudine 300 mg)

Pill with imprint APO LMV 300 is Gray, Four-sided and has been identified as Lamivudine 300 mg. It is supplied by Apotex Inc..

Lamivudine is used in the treatment of hepatitis b; nonoccupational exposure; occupational exposure; hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO LMV 300

Lamivudine 300 mg APO LMV 300
Lamivudine 300 mg APO LMV 300 Front
Lamivudine 300 mg APO LMV 300 Back
Lamivudine 300 mg APO LMV 300
Lamivudine 300 mg APO LMV 300

Lamivudine

Imprint:
APO LMV 300
Strength:
300 mg
Color:
Gray
Shape:
Four-sided
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Apotex Inc.
National Drug Code (NDC):
60505-3252

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide